Comparison of clinical characteristics of second and third peaks of COVID-19 pandemic: effects of vaccination and preventive measures
Özer Özdemir, Atakan Arslan, H. M. Bülbül, P. Özdemir
{"title":"Comparison of clinical characteristics of second and third peaks of COVID-19 pandemic: effects of vaccination and preventive measures","authors":"Özer Özdemir, Atakan Arslan, H. M. Bülbül, P. Özdemir","doi":"10.23736/s2784-8477.22.02002-2","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Understanding the differences in consequent peaks of covid-19 may guide us for better predicting future disease characteristics. in this study, we aimed to compare clinical and radiological characteristics as well as outcomes of hospitalized patients with the diagnosis of covid-19 in second and third peaks of disease. METHOD(S): We retrospectively included 303 hospitalized patients with covid-19. the study population was examined in two groups: patients hospitalized between october 2020 and January 2021 during second peak and patients hospitalized between March and June 2021 during third peak. RESULT(S): there were 171 patients in group 1 and 132 patients in group 2. the patients in group 2 were younger (64+/-13.27 vs. 56.02+/-15.39, respectively;P<0.001) and female proportion was higher (64.9% and 48.5% males;P=0.005). Smoking history and presence of comorbidities were less in group 2 (41.5% vs. 25.7%, P=0.008;and 78.5% vs. 59.1%, P<0.001) and symptom duration was shorter (median 7 days vs. 6 days, P=0.039). CT severity scores, LDH, CRP, D-dimer, Ferritin, and creatinine levels were lower in group 2 (P=0.003, P=0.008, P<0.001, P<0.001, P<0.001, respectively), and mortality ratio was lower (N.=39 [28%] vs. N.=15 [11.4%], P=0.01). Duration of hospital stay and need for intensive unit care were similar across groups (median 8 days vs. 7 days, P=0.673 and N.=39 [22.8%] vs. N.=33 [25.2%], P=0.683). CONCLUSION(S): although duration of hospital stay was lower in third peak, clinical severity scores and prognostic markers were lower compared with second peak. These may reflect the increased proportion of immunized people, and the effect of preventive measures. Copyright © 2022 EDIZIONI MINERVA MEDICA.","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"56 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Respiratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/s2784-8477.22.02002-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND: Understanding the differences in consequent peaks of covid-19 may guide us for better predicting future disease characteristics. in this study, we aimed to compare clinical and radiological characteristics as well as outcomes of hospitalized patients with the diagnosis of covid-19 in second and third peaks of disease. METHOD(S): We retrospectively included 303 hospitalized patients with covid-19. the study population was examined in two groups: patients hospitalized between october 2020 and January 2021 during second peak and patients hospitalized between March and June 2021 during third peak. RESULT(S): there were 171 patients in group 1 and 132 patients in group 2. the patients in group 2 were younger (64+/-13.27 vs. 56.02+/-15.39, respectively;P<0.001) and female proportion was higher (64.9% and 48.5% males;P=0.005). Smoking history and presence of comorbidities were less in group 2 (41.5% vs. 25.7%, P=0.008;and 78.5% vs. 59.1%, P<0.001) and symptom duration was shorter (median 7 days vs. 6 days, P=0.039). CT severity scores, LDH, CRP, D-dimer, Ferritin, and creatinine levels were lower in group 2 (P=0.003, P=0.008, P<0.001, P<0.001, P<0.001, respectively), and mortality ratio was lower (N.=39 [28%] vs. N.=15 [11.4%], P=0.01). Duration of hospital stay and need for intensive unit care were similar across groups (median 8 days vs. 7 days, P=0.673 and N.=39 [22.8%] vs. N.=33 [25.2%], P=0.683). CONCLUSION(S): although duration of hospital stay was lower in third peak, clinical severity scores and prognostic markers were lower compared with second peak. These may reflect the increased proportion of immunized people, and the effect of preventive measures. Copyright © 2022 EDIZIONI MINERVA MEDICA.
2019冠状病毒病大流行第二、第三高峰临床特征比较:疫苗接种效果及预防措施
背景:了解covid-19随后高峰的差异可能指导我们更好地预测未来的疾病特征。在本研究中,我们旨在比较在疾病第二和第三高峰诊断为COVID-19的住院患者的临床和影像学特征以及结局。方法:我们回顾性纳入了303例covid-19住院患者。研究人群分为两组:2020年10月至2021年1月期间的第二高峰住院患者和2021年3月至6月期间的第三高峰住院患者。结果:1组171例,2组132例。2组患者年龄较轻(分别为64+/-13.27 vs. 56.02+/-15.39, P<0.001),女性比例较高(男性64.9% vs. 48.5%, P=0.005)。2组吸烟史和合并症发生率较低(41.5%比25.7%,P=0.008; 78.5%比59.1%,P<0.001),症状持续时间较短(中位7天比6天,P=0.039)。2组CT严重程度评分、LDH、CRP、d -二聚体、铁蛋白、肌酐水平均低于对照组(P=0.003、P=0.008、P<0.001、P<0.001、P<0.001),死亡率低于对照组(n =39[28%]比n =15 [11.4%], P=0.01)。住院时间和重症监护需求在两组间相似(中位8天vs. 7天,P=0.673, n =39 [22.8%] vs. n =33 [25.2%], P=0.683)。结论(S):虽然第三高峰住院时间较短,但临床严重程度评分和预后指标较第二高峰低。这可能反映了免疫人群比例的增加,以及预防措施的效果。版权所有©2022 EDIZIONI MINERVA MEDICA。
本文章由计算机程序翻译,如有差异,请以英文原文为准。